Leukemia & Lymphoma
Title Abbreviation
Leuk Lymphoma
Electronic ISSN
1029-2403
Readership
Epidemiologists, Hematologists, Immunologists, Nuclear Medicine Physicians, Oncologists, Pathologists, Pharmacologists, Physicians, Radiation Oncologists, Radiologists, Researchers, Residents, Scientists
Scope
Leukemia & Lymphoma is an international peer reviewed journal that publishes research on all aspects of hematological malignancies.
The journal aims to address the needs of physicians and scientists interested in clinical, translational, laboratory and basic science research, as well as clinical diagnosis and treatment of patients with malignant hematological disorders.
Leukemia & Lymphoma covers from clinical and clinico-pathological investigations to fundamental research in the following topics: disease biology; mechanisms of action of novel agents; development of combination chemotherapy; pharmacology and pharmacogenomics; ethics and epidemiology.
Submissions of unique clinical observations or confirmatory studies are considered and published as Letters to the Editor.
The journal accepts original articles (clinical and research), review articles, letters to the editor, correspondence, commentaries, emerging drug profiles, clinical dilemmas.
Sponsoring Association(s)
No associations affiliated with this journal
Publisher Name
Taylor & Francis, Inc. - UK
Impact Factor
JCR Categories/Rank
Circulation
Electronic Circulation
Submission to Acceptance
Acceptance to Online Publication
Acceptance to Print Publication
Rejection Rate
Frequency
Journal Contact
Author Submission Guidelines